Whole-Genome Duplications Linked to Racial Disparities in Cancer Outcomes
Genomic Discovery Sheds Light on racial Disparities in Cancer Outcomes
Yale Study Finds Black Patients More Likely to Exhibit Genomic Alteration Linked to Aggressive Cancer
A groundbreaking study from Yale University’s Department of Surgery has uncovered a notable genomic phenomenon that could help explain racial disparities in cancer outcomes. Published in the prestigious journal Nature, the research reveals that tumors in Black individuals are more likely to exhibit whole-genome duplications (WGDs) compared to those from white patients.
WGDs, a type of genomic alteration where an organism’s entire genome is duplicated, can lead to more aggressive cancer progression, increased metastasis, and poorer patient prognosis. The Yale team, led by Dr. Leanne Brown, a general surgery resident, and Dr. Jason Sheltzer, Ph.D., analyzed over 1,800 cancer samples from self-reported Black patients in the United States. Their findings showed a consistent increase in wgds across various cancer types, including breast, endometrial, and lung cancers, and linked this genomic alteration to shorter survival rates for Black patients.”This discovery is a crucial step in understanding the complex factors contributing to racial disparities in cancer,” said dr. Sheltzer.”By identifying WGDs as a potential driver of these disparities,we can begin to develop more targeted and effective treatments for Black patients.”
The study also delved into the role of environmental factors, finding that exposure to combustion byproducts, such as those found in pollution and tobacco smoke, could induce WGDs in cultured cells. Tumors from Black patients exhibited mutational signatures suggesting that these environmental carcinogens may contribute to the higher frequency of WGDs observed in their cancers.
This research not only identifies a new genomic factor associated with cancer progression but also highlights the potential role of environmental exposures in racial disparities in cancer outcomes. By uncovering the link between wgds and environmental factors, the study opens new avenues for research into how these elements influence cancer biology and patient survival, especially for historically underserved populations.
Genomic Anomaly could Drive Racial Disparities in Cancer Outcomes, Yale Study Finds
New Haven, CT – A groundbreaking study from Yale University’s Department of Surgery has uncovered a potential genetic culprit behind racial disparities in cancer outcomes, raising hopes for more targeted and effective treatments for Black patients.
Published in the prestigious journal Nature, the research reveals Black patients are considerably more likely to exhibit whole-genome duplications (WGDs) in their tumors compared to their white counterparts. WGDs, a type of genomic alteration where a cell duplicates its entire DNA, are linked to more aggressive cancer progression, increased metastasis, and poorer patient prognosis.
Led by Dr. Leanne Brown, a general surgery resident, and Dr. Jason Sheltzer, Ph.D., the Yale team analyzed over 1,800 cancer samples from self-reported Black patients in the United States. Consistent WGD increases were observed across various cancer types, including breast, endometrial, and lung cancers. This genomic alteration corresponded with shorter survival rates in Black patients.
“This discovery is a crucial step in understanding the complex factors contributing to racial disparities in cancer,” said Dr. Sheltzer. “By identifying WGDs as a potential driver of these disparities, we can begin to develop more targeted and effective treatments for Black patients.”
Adding another layer of complexity, the study delved into the potential role of environmental factors, finding that exposure to combustion byproducts – such as those found in pollution and tobacco smoke – could induce WGDs in cultured cells. Tumors from Black patients bore distinct mutational signatures, suggestive of these environmental carcinogens contributing to the increased frequency of WGDs.
This research not only identifies a novel genomic factor linked to cancer progression but also underscores the potential influence of environmental exposures on racial disparities in cancer outcomes. By establishing the connection between WGDs and environmental impacts, the study paves the way for further research into how these factors influence cancer biology and patient survival, notably for historically underserved populations.